Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Methods and devices for improving cardiac function in hearts

a heart and cardiac function technology, applied in the field of apparatus for treating a failing heart, can solve the problems of significant increase in wall tension and/or stress, dilatation of the left ventricular chamber, and inability to achieve the effect of reducing the radius of curvature of the heart wall

Inactive Publication Date: 2006-07-20
EDWARDS LIFESCIENCES LLC
View PDF99 Cites 270 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The present invention provides a non-invasive method for treating heart failure due to dilatation, infarction, or aneurysm by reducing the tension in the heart wall. The invention involves the use of a splint or splints that can be placed in the heart chamber to decrease the energy consumption of the failing heart. The splint can be a full cycle splint that engages the heart wall throughout the cardiac cycle or a restrictive splint that only engages at end systole. The splint can be a tension member or a compression member, and can be used alone or in combination with other surgical techniques. The invention offers an improved method for treating heart failure that is less invasive, poses less risk to the patient, and is likely to be more clinically effective."

Problems solved by technology

Typically these processes result in dilatation of the left ventricular chamber.
With damage to the myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate.
The basic problem with a large dilated left ventricle is that there is a significant increase in wall tension and / or stress both during diastolic filling and during systolic contraction.
However, in a failing heart, the ongoing dilatation is greater than the hypertrophy and the result is a rising wall tension requirement for systolic contraction.
This is felt to be an ongoing insult to the muscle myocyte resulting in further muscle damage.
Additionally, because of the lack of cardiac output, there is generally a rise in ventricular filling pressure from several physiologic mechanisms.
These drug therapies offer some beneficial effects but do not stop the progression of the disease.
Heart transplantation has serious limitations including restricted availability of organs and adverse effects of immunosuppressive therapies required following heart transplantation.
However, this extremely invasive procedure reduces muscle mass of the heart.
The bulge resulting from an aneurysm can have several serious effects on the heart and its performance that can lead to in both morbidity and mortality.
Another serious effect this bulging can have is the denigration of the heart's pumping function.
The aneurysmal bulge creates problems with pumping function in at least three ways.
This further increases the contractile requirement of the remaining functional myocardium.
Second, the aneurysmal bulge alters the geometry of the entire ventricular chamber.
Third, over time, the above two conditions lead the functional muscle of the ventricle to work harder than normal.
This can lead to continued dilatation of the ventricle, increasing tension in the walls of the heart, with increased myocardial oxygen requirement and further progressing heart failure.
Typically, the result is the entire ventricle increasing in size, which increases wall stress.
Again, since the functioning myocardium must work harder, continuing progression of heart failure can occur.
If the infarcted or aneurysmal region is located in the vicinity of the mitral valve, geometric abnormalities may cause the mitral valve to alter its normal position and dimension, and may lead to annular dilatation and the development of mitral regurgitation.
Over time, these effects can continue to lead to progression of heart failure.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods and devices for improving cardiac function in hearts
  • Methods and devices for improving cardiac function in hearts
  • Methods and devices for improving cardiac function in hearts

Examples

Experimental program
Comparison scheme
Effect test

embodiment 116

[0125]FIG. 5 shows an alternate embodiment of the splint of FIG. 1 referred to in FIG. 5 by the numeral 116. The embodiment 116 shown in FIG. 5 includes three tension members 118 as opposed to a single tension member 18 as shown in FIG. 1. FIG. 6 shows yet another embodiment of the splint 216 having four tension members 218. It is anticipated that in some patients, the disease process of the failing heart may be so advanced that three, four or more tension members may be desirable to reduce the heart wall stresses more substantially than possible with a single tension member as shown in FIG. 1.

embodiment 316

[0126]FIG. 7 is a partial vertical cross-section of human heart 14 showing left ventricle 10. In FIG. 7, another splint embodiment 316 is shown having a tension member 318 extending through left ventricle 10. On opposite ends of tension member 318 are disposed elongate anchors or pads 320. FIG. 8 is an end view of tension member 318 showing elongate anchor 320.

[0127]FIG. 9 shows another embodiment of a splint 416 disposed in a partial vertical cross-section of human heart 14. Splint 416 includes two elongate anchors or pads 420 similar to those shown in FIGS. 7 and 8. In FIG. 9, however, two tension members 418 extend through left ventricle 10 to interconnect anchors 420 on opposite sides of heart 14.

[0128]FIG. 10 is a vertical cross section of heart 14 showing left ventricle 10. In this case, two splints 16 are disposed through left ventricle 10 and vertically spaced from each other to resemble the configuration of FIG. 9.

[0129]FIG. 11 is a vertical cross-sectional view of the le...

embodiment 156

[0132]FIG. 14 shows an alternate embodiment 156 of the splint shown in FIG. 13. In this case lever members 154 are longer than members 54 as compression member 152 of splint 150 has been disposed to the exterior of left ventricle 10.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Various methods and devices are disclosed for improving cardiac function in hearts having zones of infarcted (akinetic) and aneurysmal (dyskinetic) tissue regions. The methods and devices reduce the radius of curvature in walls of the heart proximal infarcted and aneurysmal regions to reduce wall stress and improve pumping efficiency. The inventive methods and related devices include splinting of the chamber wall proximal the infarcted region and various other devices and methods including suture and patch techniques.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation-in-part of U.S. patent application Ser. No. 09 / 124,286 filed Jul. 29, 1998, now pending, which is a continuation-in-part of U.S. patent application Ser. No. 08 / 933,456 filed Sep. 18, 1997, now pending, which is a continuation-in-part of U.S. patent application Ser. No. 08 / 778,277, filed Jan. 2, 1997, now pending.FIELD OF THE INVENTION [0002] The present invention pertains to the field of apparatus for treatment of a failing heart. In particular, the apparatus and its related methods of the present invention is directed toward reducing the wall stress in the failing heart. The present invention further includes methods and devices for improving cardiac function in hearts having discrete zones of infarcted tissue. Such methods and devices reduce the radius of curvature and / or alter the geometry or shape of the infarcted tissue and adjacent regions to thereby reduce wall stress on the heart and improve th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61M1/10A61B17/00A61B17/04A61B17/122A61B19/00A61F2/00A61F2/24
CPCA61B17/00234A61B17/04A61B17/0487A61B17/1227A61B19/54A61B2017/00243A61B2017/0404A61B2017/0435A61B2017/0445A61B2017/0446A61B2017/0454A61B2017/0458A61B2017/0464A61B2017/048A61B2017/0496A61B2019/542A61F2/2481A61F2/2487A61B2090/392A61B90/39
Inventor MCCARTHY, PATRICK M.SCHWEICH, CYRIL J. JR.MORTIER, TODD J.KEITH, PETER T.KALLOK, MICHAEL J.
Owner EDWARDS LIFESCIENCES LLC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products